Regeneron’s Global Program Head for Rimbosertamab Discusses Rimbosertamab’s Potential as a First-Line Treatment for Multiple Myeloma
In an interview with Pharm Exec deputy editor Don Tracy, Karen Rodriguez-Lorenc,…
New eCommerce Tools: June 4, 2024
This week's list of new ecommerce tools for retailers includes updates on…
Adam Smith as a Founding Father
Daniel Klein, a professor of economics at George Mason University, asked me…
I’m buying dividend aristocrats with yields up to 8.5%.
Musa 81 There are many "Buffett-isms" out there and most people know…
Cord-free LEDs and animation: Using Bekonix for lighting and props
You've used 3D printing to make awesome props, create light-up swords for…
Financial, Regulatory, and Technological Hurdles for Value-Based Care: Q&A with Matthew Hellinger and Ian Goldberger
Experts will discuss the challenges providers face as they try to offer…
Podcast: AI prescription for banks
Financial institutions look to their tech providers to help them embrace new…
Link June 4, 2024 | Naked Capitalism
Dear patient readers, You'll have a light snack when you depart, and…
Jobs Report Preview: My expectation is 150,000, S&P 500 Index will react negatively (SP500)
Nastasia Samar/iStock via Getty Images Key Labor Market Data The employment report…
Pharma Pulse 6/4/24: Google rolls back AI search feature, more GLP-1 coming, and more
The latest news for pharmaceutical industry professionals.
